인사이트
Insights From Our Experts
Articles
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services
Navigating the healthcare system can be enormously challenging for patients, who often face numerous obstacles that hinder their access to quality care. Common barriers include financial constraints, long wait times, socio-economic disparities, fragmented care coordination, among…
Strategic Market Access: Innovative Branding Strategies in Emerging Markets
Authors: Amardeep Udeshi, SVP, EVERSANA APAC; Ankit Kulshrestha, Senior Principal, EVERSANA APAC; Nishit Patadia, Engagement Manager, EVERSANA APAC In the dynamic landscape of the pharmaceutical industry, traditional linear market access approaches are no longer sufficient. This…
Launching in the EU/U.K.: The 7-Step Countdown to Success
THE LAUNCH Eager to explore the vast potential of launching your product in the EU/UK? While the mission is challenging, thorough preparations can ensure a smooth route to success. You only get one chance to launch,…
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
In today’s healthcare landscape, patients are no longer passive recipients of care. They are empowered, tech-savvy stakeholders who demand efficiency and transparency. Yet, despite advancements in consumer innovation, the healthcare system often leaves them frustrated with…
IDN Trends, Insights and Strategies Every Manufacturer Should Know
In this latest webinar, hear from three industry experts as the delve into the intricacies of integrated delivery networks (IDNs) and how they are transforming the healthcare landscape. EVERSANA’s Faruk Abdullah and Krista Pinto, and Matthew…
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Unlock the full potential of your Integrated Delivery Network (IDN) strategies with EVERSANA’s latest Market Research & Insights Report. Drug manufacturers are engaging with IDNs to address pain points and trends, optimize patient outcomes, and foster…
European Parliament’s Revision of the General Pharmaceutical Legislation
The European Parliament has adopted a revision of the general pharmaceutical legislation, repealing and amending previous legislation with a set of compromise amendments. According to the European Commission, it has been called “the largest reform in…
Market Access and the Inflation Reduction Act
The Inflation Reduction Act of 2022 (IRA) institutes Medicare changes that include the ability to negotiate drug prices, limit price increases and cap out-of-pocket costs for beneficiaries. Understanding the far-reaching implications of these provisions is crucial…
Optimizing Product Commercialization in Today’s IDN Environment
The healthcare landscape is undergoing a significant transformation with the rise of Integrated Delivery Networks (IDNs), now employing nearly 70% of U.S. physicians. As IDNs become more prevalent, they bring numerous advantages, such as enhanced physician…
Navigating the PBAC: Strategies for Successful Reimbursement Applications
Authors: Ravi Visweswara, Executive Vice President, EVERSANA APAC; Robin Arnold, Executive Vice President, EVERSANA APAC; Amish Chaturvedi, Senior Director, Pricing and Market Access, EVERSANA APAC; Paul Lindsay, Senior Director, Pricing and Market Access, EVERSANA Australia Crafting…